(
EMAILWIRE.COM, February 06, 2018 ) The
North America Liquid Biopsy market is expected to increase at a CAGR of 19.6% in the forecast period of 2016-2021 and reach a value of USD 433.29 million by 2021 from USD 177.06 million in 2016. North America is leading market for Liquid Biopsy. Liquid biopsy market is on high growth in North America as colorectal cancer stands fourth most common diagnosed cancer in the region. There is a lot of research going on for the detection of colorectal cancer. Geographically North America Market is segmented into USA and Canada.
Liquid Biopsy is an emerging non-invasive procedure that can detect cancer at very advance stage. This is done by testing a sample of blood and detecting cancer cells from the tumour. Taking various samples of the blood helps doctors understand the behaviour of the tumour over time. This technique of detecting cancer is very valuable for the doctors using targeted therapies to treat cancer.
Browse market data tables and in-depth TOC of the North America Liquid Biopsy Industry to 2021 @
http://www.marketdataforecast.com/market-reports/north-america-liquid-biopsy-market-951/Rising demand for non-invasive procedures, greater accuracy to detect cancer cells and the increasing number of cancer cases are the key factors driving the liquid biopsy market. However, the unclear regulatory and reimbursement scenario is a major area of concern in the market.
The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users.
The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.
Free sample of the report is available @
http://www.marketdataforecast.com/market-reports/north-america-liquid-biopsy-market-951/request-sampleThe key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Reasons to buy North America Liquid Biopsy Analysis Market Research Report:
• Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Inquire before Buying at
http://www.marketdataforecast.com/market-reports/north-america-liquid-biopsy-market-951/inquireAbout Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.comSource:
EmailWire.Com 
